Ipca Laboratories Ltd. benchmarking: Perfomance to industry peers

Financial

	Ipca Laboratories	Ajanta Pharma	Gland Pharma
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	44.0 .	75.0 .	384.0 .
Number of ANDA's Approved By USFDA	31.0 .	56.0 .	331.0 .
Domestic Sales Growth - YoY	13.1 %	7.5 %	n/a
US DMF Filings	55.0 .	n/a	68.0 .
R&D as a % of Total Sales	3.12 %	5.0 %	5.4 %
Financials
5 yr Average ROE	13.55 %	21.63 %	12.02 %
5yr average Equity Multiplier	1.52	1.32	1.15
5yr Average Asset Turnover Ratio	0.76	0.84	0.51
5yr Avg Net Profit Margin	11.88 %	19.77 %	20.79 %
Price to Book	4.87	8.26	3.19
P/E	43.44	35.12	36.02
5yr Avg Cash Conversion Cycle	54.3 Days	-102.34 Days	69.81 Days
Inventory Days	102.83 Days	55.16 Days	118.26 Days
Days Receivable	72.68 Days	49.8 Days	99.92 Days
Days Payable	111.38 Days	195.69 Days	107.43 Days
5yr Average Interest Coverage Ratio	50.79	108.5	183.05
5yr Avg ROCE	17.31 %	27.48 %	16.55 %
5yr Avg Operating Profit Margin	19.8 %	27.65 %	29.26 %
5 yr average Debt to Equity	0.17	0.0	0.01
5yr CAGR Net Profit	-8.34 %	7.08 %	-6.87 %
5yr Average Return on Assets	9.41 %	16.51 %	10.65 %
Shareholdings
Promoter Holding	44.72 %	66.25 %	51.83 %
Share Pledged by Promoters	0.0	17.29 %	0.0
Change in Promoter Holding (3 Yrs)	-1.57 %	0.14 %	-6.03 %
Change in Mutual Fund Holding (3 Yrs)	0.73 %	1.92 %	11.93 %

Business

	Ipca Laboratories	Ajanta Pharma	Gland Pharma
Product Wise Break-Up	Product Wise Break-Up Branded Generics 50.39 Formulations 33.08 Active Pharmaceutical Ingredient (API) 16.53 Pharmaceutical products 0 Injectables 0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceuticals 0 Active Pharmaceutical Ingredient (API) 0 Injectables 0 Branded Generics 0 Formulations 0 Pharmaceutical 100.0	Product Wise Break-Up Pharmaceutical 100.0 Active Pharmaceutical Ingredient (API) 0 Injectables 0 Branded Generics 0 Formulations 0 Pharmaceutical products 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Pain 53.0 Cardiac Science 17.0 Dermatology 6.0 Urology 5.0 Anti-bacterial 5.0 Cough and colds 4.0 Central Nervous System (CNS) 3.0 Anti Malarials 3.0 Gastro Intestinal 2.0 Neutraceuticals 1.0 0 Others 1.0	Therapeutic Area Wise Break-Up - Domestic Central Nervous System (CNS) 0 Gastro Intestinal 0 Pain 10.0 0 Dermatology 24.0 Urology 0 Cardiac Science 0 Anti Malarials 0 Neutraceuticals 0 Anti-bacterial 0 Cough and colds 0 Others 66.0	-
Location Wise Break-Up	Location Wise Break-Up India 44.73 USA 21.58 Europe 15.68 Africa 6.72 Asia Pacific 5.18 Australia 3.2 CIS 2.91 Asia 0 Canada, Australia & New Zealand 0 Canada 0	Location Wise Break-Up Canada 0 CIS 0 Europe 0 Africa 19.82 Australia 0 USA 29.19 Asia Pacific 21.07 Canada, Australia & New Zealand 0 India 29.92 Asia Pacific 0	Location Wise Break-Up Canada 0 CIS 0 Europe 19.15 Africa 0 Australia 0 USA 55.68 Asia 0 Canada, Australia & New Zealand 3.28 India 4.47 Asia Pacific 0 Others 17.42
Therapeutic Area Break-Up	Therapeutic Area Break-Up Cardiovascular & Anti Diabetics 25.0 Anti Malarials 24.0 NSAID 21.0 Neuro 7.0 GI 6.0 Cough 2.0 Nutraceuticals 0 Urology 0 Dermatology 0 Others 15.0	-	-

Ipca Laboratories Ltd.

Ipca Laboratories Ltd.

Financial

Business

SIGN UP FOR FREE